Article Text

other Versions

PDF
Do patients with low volume prostate cancer have PSA recurrence following radical prostatectomy?
  1. Bungo Furusato (bfurusato{at}cpdr.org)
  1. Department of Genitourinary Pathology, Armed Forces Institute of Pathology, Washington, DC, United States
    1. Inger L. Rosner
    1. Department of Surgery, Urology Service, Walter Reed Army Medical Center, Washington, DC, United States
      1. David Osborn
      1. Department of Surgery, Urology Service, Walter Reed Army Medical Center, Washington, DC, United States
        1. Amina Ali
        1. Center for Prostate Disease Research, United States
          1. Shiv Srivastava (ssrivastava{at}cpdr.org)
          1. Center for Prostate Disease Research, United States
            1. Charles J. Davis
            1. Department of Genitourinary Pathology, Armed Forces Institute of Pathology, Washington, DC, United States
              1. Isabell A. Sesterhenn (sesterhe{at}afip.osd.mil)
              1. Department of Genitourinary Pathology, Armed Forces Institute of Pathology, Washington, DC, United States
                1. David G. McLeod (dgmcleod{at}verizon.net)
                1. Center for Prostate Disease Research, United States

                  Abstract

                  Aims: The objective of this study is to determine the incidence of PSA relapse in patients with low volume prostate cancer following radical prostatectomy.

                  Methods: Between 1993 and 2001, 50 of 717 patients had total tumor volumes of less than 0.5 cc following radical prostatectomy. Biochemical recurrence was defined as two consecutive values of serum PSA levels of 0.2 ng/mL or greater.

                  Results: Median follow-up of the 50 patients was 58 months. In five of the 50 patients (10%), PSA recurrence was observed. All of these five cases had Gleason score of 3+3 (well and /or moderately differentiated), organ confined and surgical margin negative tumors. In three of the five cases, capsular incision resulted in benign glands extending into the surgical margin.

                  Conclusions: Five of 50 cases had PSA failure. In three of the five patients, benign glands located in the margin could explain the “PSA recurrence”. However, in the other two patients, none of the pathological parameters correlated with measurable PSA levels. The explanation for their PSA failure is unclear.

                  Statistics from Altmetric.com

                  Request permissions

                  If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.